<DOC>
	<DOCNO>NCT02738606</DOCNO>
	<brief_summary>The goal clinical research study compare effect liver resection standard care chemotherapy standard care chemotherapy alone patient whose colorectal cancer spread liver lung .</brief_summary>
	<brief_title>Trial Liver Resection Versus No Surgery Patients With Liver Unresectable Pulmonary Metastases From Colorectal Cancer ( Liver Resection With Unresectable Lung Nodules From Colorectal Adenocarcinoma - LUNA )</brief_title>
	<detailed_description>Study Groups : If find eligible take part study , randomly assign ( flip coin ) 1 2 study group . This do one know one study group well , , bad group . You equal chance assign either group . - If assign Group 1 , liver resection surgery , follow standard care chemotherapy . The chemotherapy receive depend doctor think best interest . - If assign Group 2 , receive standard care chemotherapy doctor think best interest . You sign separate consent form explain standard care chemotherapy work , chemotherapy schedule , risk . Group 1 : If Group 1 , standard care liver resection surgery . A portion liver affect tumor remove either many small incision one large incision . An ultrasound device use help doctor see affected area . The study doctor explain procedure detail sign separate consent form explain standard care surgery risk . Study Visits : Both group study visit every 3-6 month study . The following test procedure perform : - You physical exam . - You chest x-ray CT scan check status disease . - You abdominal pelvic CT scan , PET/CT scan , MRI scan check status disease . - Blood ( 3 tablespoon ) draw routine test . - Blood ( 2 teaspoon ) draw biomarker testing . - You complete quality life survey complete screening . Length Study : You study 3 year . You take study disease get bad intolerable side effect occur . This investigational study . Liver resection surgery patient colorectal cancer able resect do standard technique use FDA-approved device . Liver resection surgery patient colorectal cancer partially resect consider investigational . Up 80 participant take part study . All enrol MD Anderson .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>1 . Patients synchronous metachronous diagnosis resectable liver metastasis compute tomography ( CT ) magnetic resonance imaging ( MRI ) abdomen : ) Patients require percutaneous intraoperative ablation liver metastases &lt; 2 cm size eligible . b ) Patients underwent prior liver resection ablation colorectal liver metastases eligible . 2 . Patients previously treat systemic chemotherapy and/or biologic agent colorectal cancer eligible . 3 . The primary tumor colon rectum may intact resect . 4 . Lowvolume lung metastasis define solid pulmonary nodule &lt; 2 cm nonspiculated contour , benignappearing calcification , &lt; /= 14 number , diagnose compute tomography chest positron emission tomography ( PET ) . 5 . Lung metastases unresectable due anatomic location , distribution , patient ' comorbidities , determine review image faculty member Department Thoracic &amp; Cardiovascular Surgery . 6 . Patients 18 year age old . 7 . Patients must sign studyspecific consent form . 8 . Patients undergo CT imaging chest , abdomen , pelvis evaluate lung liver metastasis within 30 day registration . For patient tolerate CT contrast hepatic steatosis reduces sensitivity CT , MRI liver perform . 1 . Radiographic evidence disease liver lung , exception mediastinal lymph node &lt; 2 cm hepatoduodenal ligament lymphadenopathy , diagnose compute tomography , magnetic resonance imaging , positron emission tomography . 2 . Inadequate liver function , evidence serum bilirubin &gt; /= 2 mg/dL , international normalize ratio ( INR ) &gt; /= 1.7 , and/or platelet count &lt; 50,000/microL . 3 . Eastern Cooperative Oncology Group ( ECOG ) performance status 34 . 4 . Patient refusal participate randomization . 5 . Pregnant woman exclude study . 6 . Planned stereotactic body radiation therapy ( SBRT ) pulmonary metastasis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Colorectal Cancer</keyword>
	<keyword>Other disease intestine</keyword>
	<keyword>Liver Unresectable Pulmonary Metastases</keyword>
	<keyword>Resectable liver metastasis</keyword>
	<keyword>Liver resection</keyword>
	<keyword>Chemotherapy</keyword>
</DOC>